Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Signs on FedMed, ACPN for Increased Access to ConfirmMDx Test

NEW YORK (GenomeWeb News) – MDxHealth today announced it signed agreements with health insurance providers FedMed and America's Choice Provider Network, extending access to the company's ConfirmMDx prostate cancer test to 50 million additional lives.

FedMed has 40 million covered lives, while ACPN has 11.2 million lives, MDxHealth said. The firm said that more than 130 million covered lives now have access to the ConfirmMDx test.

The signings are the most recent in a string of deals announced by MDxHealth related to insurance coverage for the test. A month ago, it inked a deal with preferred provider organization Stratose. During the summer, the company also reached agreements with healthcare cost management firm MultiPlan and PPO Three Rivers Provider Network.